SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
D. Bojkova, J. E. McGreig, K.-M. McLaughlin, S. G. Masterson, M. Widera, V. Kraehling, S. Ciesek, M. N. Wass, M. Michaelis, J. N. Cinatl
This study compares SARS-CoV-2 and SARS-CoV in cell tropism and drug sensitivity, finding differences in conservation, receptor usage, and therapeutic responses to aprotinin and remdesivir.
bioRxiv · Apr 3, 2020 · PreprintMicrobiology